Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management.
Saved in:
| Title: | Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management. |
|---|---|
| Authors: | Pathmanathan S; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia., Tariq A; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Pearce A; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Wesley Urology Clinic, The Wesley Hospital, Brisbane, Queensland, Australia., Rhee H; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Department of Urology, Princess Alexandra Hospital, Brisbane, Queensland, Australia., Kyle S; Department of, Medical Imaging, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Department of Nuclear Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia., Raveenthiran S; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.; Department of Urology, Redcliffe Hospital, Brisbane, Queensland, Australia., Wong D; I-MED Radiology, The Wesley Hospital, Brisbane, Queensland, Australia., McBean R; I-MED Radiology, The Wesley Hospital, Brisbane, Queensland, Australia., Marsh P; Department of Diagnostic Radiology, Princess Alexandra Hospital, Brisbane, Queensland, Australia., Goodman S; Department of Nuclear Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia., Dhiantravan N; Department of Nuclear Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia., Esler R; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.; Wesley Urology Clinic, The Wesley Hospital, Brisbane, Queensland, Australia., Dunglison N; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Navaratnam A; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Yaxley J; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Wesley Urology Clinic, The Wesley Hospital, Brisbane, Queensland, Australia., Thomas P; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Department of Nuclear Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia., Pattison DA; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Department of Nuclear Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia., Goh JC; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Gan CL; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia., Roberts MJ; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia. m.roberts2@uq.edu.au.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia. m.roberts2@uq.edu.au.; Department of Urology, Redcliffe Hospital, Brisbane, Queensland, Australia. m.roberts2@uq.edu.au.; Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia. m.roberts2@uq.edu.au. |
| Source: | European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Dec; Vol. 51 (1), pp. 295-303. Date of Electronic Publication: 2023 Aug 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
